Trend Results : Kettering Cancer Center

Blog Post Results (1-20 of 50)


In lung cancer, not all HER2 alterations are created equal

A joint study by University of Colorado Cancer Center and Memorial Sloan Kettering Cancer Center published in the Journal of Thoracic Oncology shows two distinct causes of HER2 activation in lung cancer: mutation of the gene and amplification of the gene. Show More Summary

The Future of Outpatient Cancer Surgery Takes Shape with New, First-of-Its-Kind Facility

A major transformation is beginning in cancer surgery that will enable patients to go home within a day of undergoing a significant operation. The new Josie Robertson Surgery Center (JRSC), opened by Memorial Sloan Kettering, exemplifies that transformation: a patient-focused facility that leverages technology and highly trained clinical teams to provide optimal care.

Why the U.S. should pay Irish drug prices if Pfizer wants to pay Irish tax rates

This is a guest post by Dr. Peter B. Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York City. Last week, the drug giant Pfizer announced its plan to become an Irish drug company, moving its corporate headquarters abroad as part of a complex business maneuver […]

Reinventing Cancer Surgery--By Designing A Better Hospital Experience

Memorial Sloan Kettering's new $300 million cancer center focuses on the well-being of the patient—even as they move you through the process as quickly as possible. Picture a hospital: Bright lights, buzzing machines, crowded waiting rooms, and frazzled nurses. Show More Summary

Maryland Robot Will Attend School For Cancer-Stricken 10-Year-Old Girl

A robot is set to attend school for a 10-year-old girl with cancer and it will be in school for five weeks while she undergoes cancer treatment at Memorial Sloan Kettering Cancer Center in New York, a report from NBC Washington says....Show More Summary

Lawsuit Accuses Sloan Kettering of Delaying Gene Therapy for Rare Blood Disease

4 months agoHealth : NYTimes: Health

A father is battling Memorial Sloan Kettering Cancer Center over the rights to developing a gene therapy that he hopes could cure his son’s blood disease.

Study Examines Cancer-Care Outcomes Among US Hospitals

A new JAMA Oncology study from Memorial Sloan Kettering Cancer Center finds that risk-adjusted Medicare claims data -- without information about the cancer stage of individual patients -- may be sufficient to calculate the long-term survival rates at hospitals providing cancer care in the United States.

Cornell, Sloan Kettering Partner in $10M Cancer Center

Cornell University, in partnership with Memorial Sloan Kettering Cancer Center (MSKCC), is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology.

Academics received $55 million to serve on health care company boards in 2013

Craig B. Thompson leads one of the country's most prestigious cancer hospitals, Memorial Sloan Kettering Cancer Center in New York. But noticeably absent from his online biographical sketch is his position as a director of one of the world’s biggest pharmaceutical companies, Merck, where over the past four years, he's received more than $1 million to serve on […]

Memorial Sloan Kettering Cancer Center Researchers Publish Landmark "Basket Study"

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients' tumors rather than where their cancer originated.

Lehigh Valley Health Network to Join Memorial Sloan Kettering Cancer Alliance

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.

Memorial Sloan Kettering pays $37 million for NJ property

Chambers Street Properties, a real estate investment trust, has sold a Montvale, N.J., property to a subsidiary of Memorial Sloan Kettering Cancer Center for $37 million. The 142,500-square-foot... To view the full story, click the title link.

Pereira & O’Dell Shares Survival Stories for Memorial Sloan Kettering

Pereira & O’Dell New York unveiled the next phase of its “More science. Less fear.” campaign for Memorial Sloan Kettering Cancer Center, which launched last September, marking the agency’s first effort for the client since winning agency of record duties in February, 2014. Show More Summary

Ad of the Day: Memorial Sloan Kettering Tells Three Powerful, Inspiring Cancer Stories

Giving people a new way to think and talk about cancer." That's the mission of three Internet films from New York's Memorial Sloan Kettering Cancer Center, according to chief communications officer Avice Meehan. "We started to frameShow More Summary

Statins Show Promise to Reduce Major Complications Following Lung Surgery

Statins have been shown to reduce complications from cardiovascular surgery. To determine whether statins might also help those undergoing major lung surgeries, a team at Memorial Sloan Kettering Cancer Center conducted a well-designed study that randomized patients to receive either a statin or placebo before and after surgery. Show More Summary

The Who's Daltrey Visits Teen Cancer Space At Memorial Sloan Kettering

Roger Daltrey, the Rock And Roll Hall Of Fame crooner, was in New York this week. Yes, it was for The Who’s 50th Anniversary Tour but, as importantly, the rock icon was checking progress on a teen cancer center being developed at Memorial Sloan Kettering. In 2012, Daltrey and Elvis [...]

Memorial Sloan Kettering Cancer Center "Specializes in You" with an Innovative and Personalized Digital Landscape

Memorial Sloan Kettering Cancer Center (MSK) introduced a new, consumer-friendly web presence for (Memorial Sloan Kettering Cancer Center) and (Louis V. Gerstner, Jr. Graduate School of Biomedical...Show More Summary

Memorial Sloan Kettering Opens First Pediatric CAR T Cell Clinical Trial

Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.

Future of cancer treatment at the World Economic Forum

CBS News medical contributor Dr. David Agus speaks with Dr. Jose Baselga, physician-in-chief and chief medical officer of Memorial Sloan Kettering Cancer Center, about the future of cancer treatment and genome mapping.

Skin cancer meets its worst nightmare: IBM

The effort --- a partnership with Memorial Sloan Kettering Cancer Center --- is said to detect the disease with 97 percent accuracy.

Copyright © 2015 Regator, LLC